149 related articles for article (PubMed ID: 32920499)
21. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
22. Distinct MR Imaging Features of Triple-Negative Breast Cancer with Brain Metastasis.
Yeh RH; Yu JC; Chu CH; Ho CL; Kao HW; Liao GS; Chen HW; Kao WY; Yu CP; Chao TY; Dai MS
J Neuroimaging; 2015; 25(3):474-81. PubMed ID: 25060327
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of breast cancer patients with brain metastasis treated with radiotherapy.
Simonsen MK; Vrou Offersen B; Jensen AB
Acta Oncol; 2023 Aug; 62(8):871-879. PubMed ID: 37498539
[TBL] [Abstract][Full Text] [Related]
24. Interactive effects of molecular subtypes with tumor size and extracranial metastatic pattern on risk of brain metastasis in breast cancer patients: A population-based study.
Shen B; Li J; Yang M; Liu K; Zhang J; Li W; Zhang Y; Wang K
Cancer Med; 2023 Mar; 12(6):6547-6557. PubMed ID: 36353772
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
[TBL] [Abstract][Full Text] [Related]
26. Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery.
Michel A; Dinger TF; Santos AN; Pierscianek D; Darkwah Oppong M; Ahmadipour Y; Dammann P; Wrede KH; Hense J; Pöttgen C; Iannaccone A; Kimmig R; Sure U; Jabbarli R
J Neurooncol; 2022 Aug; 159(1):53-63. PubMed ID: 35672530
[TBL] [Abstract][Full Text] [Related]
27. Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors.
Berghoff AS; Bago-Horvath Z; Ilhan-Mutlu A; Magerle M; Dieckmann K; Marosi C; Birner P; Widhalm G; Steger GG; Zielinski CC; Bartsch R; Preusser M
Br J Cancer; 2012 Oct; 107(9):1454-8. PubMed ID: 23047551
[TBL] [Abstract][Full Text] [Related]
28. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.
Jin J; Gao Y; Zhang J; Wang L; Wang B; Cao J; Shao Z; Wang Z
BMC Cancer; 2018 Apr; 18(1):446. PubMed ID: 29673325
[TBL] [Abstract][Full Text] [Related]
29. Association of the neutrophil-to-lymphocyte ratio with brain metastases in Hispanic breast cancer patients.
Cacho-Díaz B; Cortes-Ortega MD; Reynoso-Noverón N; Wegman-Ostrosky T; Arriaga-Canon C; Bargalló-Rocha JE
Cancer Treat Res Commun; 2021; 29():100452. PubMed ID: 34517195
[TBL] [Abstract][Full Text] [Related]
30. Assessment of prognostic scores in brain metastases from breast cancer.
Tabouret E; Metellus P; Gonçalves A; Esterni B; Charaffe-Jauffret E; Viens P; Tallet A
Neuro Oncol; 2014 Mar; 16(3):421-8. PubMed ID: 24311640
[TBL] [Abstract][Full Text] [Related]
31. Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up.
Matsuo S; Watanabe J; Mitsuya K; Hayashi N; Nakasu Y; Hayashi M
Breast Cancer Res Treat; 2017 Feb; 162(1):169-179. PubMed ID: 28084583
[TBL] [Abstract][Full Text] [Related]
32. Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast-GPA 0-2.0.
Ou D; Cao L; Xu C; Kirova Y; Chen JY
Breast J; 2019 Nov; 25(6):1134-1142. PubMed ID: 31286612
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
[TBL] [Abstract][Full Text] [Related]
34. Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry.
Laakmann E; Witzel I; Scriba V; Grzyska U; Zu Eulenburg C; Burchardi N; Hesse T; Würschmidt F; Fehm T; Möbus V; von Minckwitz G; Loibl S; Park-Simon TW; Mueller V
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669228
[TBL] [Abstract][Full Text] [Related]
35. Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.
Niikura N; Hayashi N; Masuda N; Takashima S; Nakamura R; Watanabe K; Kanbayashi C; Ishida M; Hozumi Y; Tsuneizumi M; Kondo N; Naito Y; Honda Y; Matsui A; Fujisawa T; Oshitanai R; Yasojima H; Tokuda Y; Saji S; Iwata H
Breast Cancer Res Treat; 2014 Aug; 147(1):103-12. PubMed ID: 25106661
[TBL] [Abstract][Full Text] [Related]
36. Metastatic breast cancer subtypes and central nervous system metastases.
Aversa C; Rossi V; Geuna E; Martinello R; Milani A; Redana S; Valabrega G; Aglietta M; Montemurro F
Breast; 2014 Oct; 23(5):623-8. PubMed ID: 24993072
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
[TBL] [Abstract][Full Text] [Related]
38. Subtype switching in breast cancer brain metastases: a multicenter analysis.
Hulsbergen AFC; Claes A; Kavouridis VK; Ansaripour A; Nogarede C; Hughes ME; Smith TR; Brastianos PK; Verhoeff JJC; Lin NU; Broekman MLD
Neuro Oncol; 2020 Aug; 22(8):1173-1181. PubMed ID: 31970416
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.
Stemmler HJ; Kahlert S; Siekiera W; Untch M; Heinrich B; Heinemann V
Breast; 2006 Apr; 15(2):219-25. PubMed ID: 16026983
[TBL] [Abstract][Full Text] [Related]
40. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
